VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$0.13
-0.01 (-6.53%)
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +22,111.0% upside
Low Target $25.08
Average Target $28.63
High Target $44.18
Current Price $0.13
Current
$0.13
Target
$28.63
$25.08 $28.63 avg $44.18
Scenario Analysis
Bear Case
$25.08
19,356.9%
Low target
Base Case
$28.63
+22,111.0%
Avg target
Bull Case
$44.18
+34,174.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.40
-96.2% from high
52-Week Low
$0.14
+-5.0% from low
Target vs 52W High
$28.63
+742.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%